Adam Savitz insider trades: Alto Neuroscience (ANRO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Adam reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 10, 2024 | ANRO | ↑ Buy | 15,000 | $12.72 | $191K | By Trust | Jul 11, 2024 (1d) |
| Feb 6, 2024 | ANRO | ↑ Buy | 17,000 | $16.00 | $272K | By Trust | Feb 7, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANRO insiders
Open-market trades in the last 12 months
About Adam Savitz's insider trades
Adam Savitz is Chief Medical Officer at Alto Neuroscience (ANRO). Since Feb 6, 2024, Adam has reported 2 open-market purchases worth $463K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings), shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANRO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.